We performed WGS on 23 MNX1-expressing primary AML samples (whole blood or BM) taken at diagnosis, which we combined with WGS data of eight samples provided by the Munich Leukemia Laboratory (MLL), resulting in a total of 31 MNX1-expressing samples profiled with WGS. The gene discussed is KMT2A; the disease is acute myeloid leukemia.